<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font23 { font-size : 23; } .font26 { font-size : 26; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">DAA </span>
   <span class="font30">treatment </span>
   <span class="font26">therapy </span>
   <span class="font23">costs </span>
   <span class="font23">cost </span>
   <span class="font23">SVR </span>
   <span class="font23">patients </span>
   <span class="font20">study </span>
   <span class="font19">[]. </span>
   <span class="font19">cirrhosis </span>
   <span class="font18">data </span>
   <span class="font18">disease </span>
   <span class="font18">model </span>
   <span class="font17">Health </span>
   <span class="font17">triple </span>
   <span class="font17">hepatitis </span>
   <span class="font17">results </span>
   <span class="font16">{border-style </span>
   <span class="font16">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">HCV </span>
   <span class="font15">Hepatitis </span>
   <span class="font15">effectiveness </span>
   <span class="font15">rates </span>
   <span class="font15">occupational </span>
   <span class="font15">years </span>
   <span class="font15">DAAs </span>
   <span class="font14">RWA </span>
   <span class="font14">analysis </span>
   <span class="font14">interferon-based </span>
   <span class="font14">therapies </span>
   <span class="font14">used </span>
   <span class="font14">using </span>
   <span class="font14">Markov </span>
   <span class="font14">SOF </span>
   <span class="font14">compared </span>
   <span class="font14">pension </span>
   <span class="font13">Figure </span>
   <span class="font13">ICER </span>
   <span class="font13">Stahmeyer </span>
   <span class="font13">based </span>
   <span class="font13">carcinoma </span>
   <span class="font13">clinical </span>
   <span class="font13">insured </span>
   <span class="font13">life </span>
   <span class="font13">medical </span>
   <span class="font13">status </span>
   <span class="font13">benefits </span>
   <span class="font13">experience </span>
   <span class="font13">treatments </span>
   <span class="font13">(SVR) </span>
   <span class="font13">... </span>
   <span class="font13">German </span>
   <span class="font13">Germany </span>
   <span class="font13">Table </span>
   <span class="font13">antiviral </span>
   <span class="font13">applied </span>
   <span class="font13">chronic </span>
   <span class="font13">cohort </span>
   <span class="font13">higher </span>
   <span class="font13">information </span>
   <span class="font13">regimens </span>
   <span class="font13">result </span>
   <span class="font13">treatment. </span>
   <span class="font12">CHC </span>
   <span class="font12">Decompensated </span>
   <span class="font12">associated </span>
   <span class="font12">available </span>
   <span class="font12">comparison </span>
   <span class="font12">cost-effectiveness </span>
   <span class="font12">health </span>
   <span class="font12">high </span>
   <span class="font12">impact </span>
   <span class="font12">infection </span>
   <span class="font12">px; </span>
   <span class="font12">rate </span>
   <span class="font12">therapies. </span>
   <span class="font12">treated </span>
   <span class="font12">value </span>
   <span class="font12">{font-family </span>
   <span class="font12">BGW. </span>
   <span class="font12">Cirrhotic </span>
   <span class="font12">DAAs, </span>
   <span class="font12">Treatment </span>
   <span class="font12">[,,,,] </span>
   <span class="font12">assumed </span>
   <span class="font12">font-size </span>
   <span class="font12">hepatocellular </span>
   <span class="font12">literature </span>
   <span class="font12">model. </span>
   <span class="font12">outcomes </span>
   <span class="font12">present </span>
   <span class="font12">ribavirin </span>
   <span class="font12">values </span>
   <span class="font12">BGW </span>
   <span class="font12">Data </span>
   <span class="font12">Hepatocellular </span>
   <span class="font12">Non-cirrhotic </span>
   <span class="font12">[,]. </span>
   <span class="font12">[], </span>
   <span class="font12">additional </span>
   <span class="font12">benefit </span>
   <span class="font12">care </span>
   <span class="font12">cirrhotic </span>
   <span class="font12">der </span>
   <span class="font12">direct-acting </span>
   <span class="font12">diseases </span>
   <span class="font12">double; </span>
   <span class="font12">genotype </span>
   <span class="font12">interferon-free </span>
   <span class="font12">overall </span>
   <span class="font12">patient </span>
   <span class="font12">payments </span>
   <span class="font12">regimen </span>
   <span class="font12">response </span>
   <span class="font12">second-generation </span>
   <span class="font12">sensitivity </span>
   <span class="font12">therapy. </span>
   <span class="font12">total </span>
   <span class="font11">(Figure </span>
   <span class="font11">A.N.; </span>
   <span class="font11">Analysis </span>
   <span class="font11">Cost </span>
   <span class="font11">Costs </span>
   <span class="font11">Efficiency </span>
   <span class="font11">Hepatol../j.jhep... </span>
   <span class="font11">LDV </span>
   <span class="font11">Liver </span>
   <span class="font11">Liver-related </span>
   <span class="font11">M.K., </span>
   <span class="font11">M.R., </span>
   <span class="font11">Public </span>
   <span class="font11">RBV </span>
   <span class="font11">Reporting </span>
   <span class="font11">Services </span>
   <span class="font11">Transplant </span>
   <span class="font11">Triple </span>
   <span class="font11">United </span>
   <span class="font11">[,,]. </span>
   <span class="font11">accident </span>
   <span class="font11">account </span>
   <span class="font11">advanced </span>
   <span class="font11">analyse </span>
   <span class="font11">analysed </span>
   <span class="font11">analysis, </span>
   <span class="font11">annual </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cases </span>
   <span class="font11">death </span>
   <span class="font11">group </span>
   <span class="font11">insurance </span>
   <span class="font11">interferon </span>
   <span class="font11">line </span>
   <span class="font11">liver </span>
   <span class="font11">long-term </span>
   <span class="font11">non-cirrhotic </span>
   <span class="font11">patients, </span>
   <span class="font11">percentage </span>
   <span class="font11">persons </span>
   <span class="font11">progression </span>
   <span class="font11">records </span>
   <span class="font11">resulted </span>
   <span class="font11">significant </span>
   <span class="font11">solid; </span>
   <span class="font11">statuses </span>
   <span class="font11">statutory </span>
   <span class="font11">studies </span>
   <span class="font11">study, </span>
   <span class="font11">taken </span>
   <span class="font11">virologic </span>
   <span class="font11">weeks </span>
   <span class="font11">years. </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">(in </span>
   <span class="font11">Based </span>
   <span class="font11">C.W., </span>
   <span class="font11">CEA </span>
   <span class="font11">Evaluation </span>
   <span class="font11">Gastroenterol. </span>
   <span class="font11">Germany. </span>
   <span class="font11">However, </span>
   <span class="font11">Institute </span>
   <span class="font11">Koch </span>
   <span class="font11">Medical </span>
   <span class="font11">Microsoft </span>
   <span class="font11">PEG-IFN </span>
   <span class="font11">Patients </span>
   <span class="font11">Percentage </span>
   <span class="font11">QALYs </span>
   <span class="font11">Quality </span>
   <span class="font11">Robert </span>
   <span class="font11">State </span>
   <span class="font11">Therapie </span>
   <span class="font11">Version </span>
   <span class="font11">Westermann </span>
   <span class="font11">[]; </span>
   <span class="font11">account. </span>
   <span class="font11">analyses </span>
   <span class="font11">analysis. </span>
   <span class="font11">application </span>
   <span class="font11">approximately </span>
   <span class="font11">average </span>
   <span class="font11">bold </span>
   <span class="font11">calculated </span>
   <span class="font11">case </span>
   <span class="font11">cohort, </span>
   <span class="font11">comparable </span>
   <span class="font11">correlation </span>
   <span class="font11">costs, </span>
   <span class="font11">courier; </span>
   <span class="font11">course </span>
   <span class="font11">decompensated </span>
   <span class="font11">determined </span>
   <span class="font11">developed </span>
   <span class="font11">direct </span>
   <span class="font11">drugs, </span>
   <span class="font11">effective </span>
   <span class="font11">effects </span>
   <span class="font11">em; </span>
   <span class="font11">end </span>
   <span class="font11">findings </span>
   <span class="font11">future </span>
   <span class="font11">ijerph---t_Table </span>
   <span class="font11">indirect </span>
   <span class="font11">infected </span>
   <span class="font11">international </span>
   <span class="font11">pay </span>
   <span class="font11">pensions </span>
   <span class="font11">performed </span>
   <span class="font11">period </span>
   <span class="font11">probabilities </span>
   <span class="font11">pt;} </span>
   <span class="font11">ratio </span>
   <span class="font11">reduction </span>
   <span class="font11">regarding </span>
   <span class="font11">retrospective </span>
   <span class="font11">routine </span>
   <span class="font11">stages </span>
   <span class="font11">standardised </span>
   <span class="font11">success </span>
   <span class="font11">takes </span>
   <span class="font11">therapy, </span>
   <span class="font11">transition </span>
   <span class="font11">treatment, </span>
   <span class="font11">und </span>
   <span class="font11">varied </span>
   <span class="font11">work </span>
   <span class="font11">year) </span>
  </p>
 </body>
</html>
